Showing results (211-220 of 318) with videos related to

Sort By:
Pageof 32
Therapeutic Advances in Medical Oncology|August 19, 2021
TGFBR2 mutation predicts resistance to immune checkpoint inhibitors in patients with non-small cell lung cancerTeng Li, Han Wang, Jiachen Xu, et al.
Thoracic Cancer|October 17, 2018
Real world study of the continuation of bevacizumab beyond disease progression after first-line treatment containing bevacizumab in Chinese patients with advanced non-small cell lung cancerPuyuan Xing, Yuxin Mu, Yan Wang, et al.
Thoracic Cancer|May 17, 2018
Real world study of regimen containing bevacizumab as first-line therapy in Chinese patients with advanced non-small cell lung cancerPuyuan Xing, Yuxin Mu, Yan Wang, et al.
Signal Transduction and Targeted Therapy|October 1, 2024
Mechanism exploration and model construction for small cell transformation in EGFR-mutant lung adenocarcinomasYan Li, Tongji Xie, Shouzheng Wang, et al.
Toxics|February 26, 2026
Atmospheric Carbonyl Compounds at Shangdianzi, Beijing: Autumn-to-Winter Variation, Ozone Formation Potential, and Source ApportionmentYufei Song, Xiaoshuai Gao, Junling Li, et al.
Human Pathology|November 27, 2020
Clinicopathological features and prognostic analysis of 247 small cell lung cancer with limited-stage after surgeryLi Liu, Jiacong Wei, Fei Teng, et al.
Thoracic Cancer|December 21, 2021
ASCL1 and DLL3 expressions and their clinicopathological implications in surgically resected pure small cell lung cancer: A study of 247 cases from the National Cancer Center of ChinaChunfang Hu, Jiyan Dong, Li Liu, et al.
Translational Oncology|February 26, 2022
Clinical significance of ALDH1A1 expression and its association with E-cadherin and N-cadherin in resected large cell neuroendocrine carcinomaJinyao Zhang, Xujie Sun, Li Liu, et al.
Experimental Hematology & Oncology|January 8, 2025
A cohort-based multi-omics identifies nuclear translocation of eIF5B /PD-L1/CD44 complex as the target to overcome Osimertinib resistance of ARID1A-deficient lung adenocarcinomaDantong Sun, Helei Hou, Feiyue Feng, et al.
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|September 9, 2024
Efficacy and safety of dacomitinib as first-line treatment for advanced non-small cell lung cancer patients with epidermal growth factor receptor 21L858R mutation: A multicenter, case-series study in ChinaShouzheng Wang, Jiayu Liu, Yan Wang, et al.
Pageof 32